Subclinical thyrotoxicosis in an outpatient population-predictors of outcome

Clinical Endocrinology

Volumn 74, Issue 2, 2011, Pages 257-261

  Schouten, Belinda J ^a   Brownlie, Bevan E W ^a   Frampton, Chris M ^b   Turner, John G ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PERTECHNETIC ACID TC 99M; THYROID ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GOITER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCLINICAL THYROTOXICOSIS; THYROID NODULE; THYROID SCINTISCANNING; THYROTOXICOSIS;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTHYROIDISM; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; THYROTOXICOSIS;

EID: 78651325706     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03908.x     Document Type: Article

References (28)

1. Seth, J., Kellett, H.A., Caldwell, G., et al. (1984) A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyrotrophin releasing hormone test? British Medical Journal, 289, 1334-1336.
2. Col, N.F., Surks, M.I., &, Daniels, G., (2004) Subclinical Thyroid Disease. Clinical applications. Journal of the American Medical Association, 291, 239-243.
3. Parle, J.V., Franklyn, J.A., Cross, K.W., et al. (1993) Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. British Journal of General Practice, 43, 107-109.
4. Laurberg, P., Pedersen, K.M., Hreidarsson, A., et al. (1998) Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. Journal of Clinical Endocrinology and Metabolism, 83, 765-769.
5. Surks, M.I., &, Boucai, L., (2010) Age-and race-based serum thyrotrophin reference limits. Journal of Clinical Endocrinology and Metabolism, 95, 496-502.
6. Malarkey, W.B., Hall, J.C., Rice, R.R., et al. (1993) The influence of age on endocrine responses to ultraendurance stress. Journal of Gerontology, 48, 134-139.
7. Olsen, T., Laurbery, P., &, Weeke, J., (1978) Low serum triiodothyronine and high serum reverse triiodothyronine in old age: an effect of disease not age. Journal of Clinical Endocrinology and Metabolism, 47, 1111-1115.
8. Mariotti, S., Barbesino, G., Caturegli, P., et al. (1993) Complex alterations of thyroid function in healthy centenarians. Journal of Clinical Endocrinology and Metabolism, 77, 1130-1134.
9. Gregermen, R.I., Gaffney, G.W., Shock, N.W., et al. (1962) Thyroxine turnover in euthyroid man with special reference to changes with age. Journal of Clinical Investigation, 41, 2065-2074.
10. Hollowell, J., Staehling, N., Flanders, D., et al. (2002) Serum TSH, T4, and thyroid antibodies in the united states population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 87, 489-499.
11. Canaris, G.J., Manowitz, N.R., Mayor, G., et al. (2000) The Colorado Thyroid Disease Prevalence Study. Archives of Internal Medicine, 160, 526-534.
12. Surks, M.I., Ortiz, E., Daniels, G.H., et al. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association, 291, 228-238.
13. Gharib, H., Tuttle, R.M., Baskin, H.J., et al. (2005) Consensus Statement: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Journal of Clinical Endocrinology and Metabolism, 90, 581-585. (Pubitemid 40116712)
14. Rosario, P.W., (2008) The natural history of subclinical hyperthyroidism in patients below the age of 65 years. Clinical Endocrinology, 68, 491-492.
15. Woeber, K.A., (2005) Observations concerning the natural history of subclinical hyperthyroidism. Thyroid, 15, 687-691.
16. Mitchell, A.L., &, Pearce, S.H.S., (2010) How should we treat patients with low serum thyrotropin concentrations? Clinical Endocrinology, 72, 292-296.
17. Biondi, B., &, Cooper, D.S., (2008) The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews, 29, 76-131.
18. Cooper, D.S., (2007) Approach to the patient with subclinical hyperthyroidism. Journal of clinical Endocrinology and Metabolism, 92, 3-9.
19. Parle, J.V., Franklyn, J.A., Cross, K.W., et al. (1991) Prevalence and follow-up of a abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clinical Endocrinology, 34, 77-83.
20. Diez, J.J., &, Iglesias, P., (2009) An analysis of the natural course of subclinical hyperthyroidism. The American Journal of the Medical Sciences, 337, 225-232.
21. Bonnema, S.J., Bennedcaek, F.N., Ladenson, P.W., et al. (2002) Management of the nontoxic multinodular goiter: a North American survery. Journal of Clinical Endocrinology and Metabolism, 87, 112-117.
22. de Benoist, B., Anderson, M., Egli, I., et al. (2004) Iodine Status Worldwide: WHO Global Database on Iodine Deficiency. World Health Organization, Geneva.
23. Thomson, C.D., (2004) Selenium and iodine intakes and status in New Zealand and Australia. British Journal of Nutrition, 91, 661-672.
24. Laurberg, P., Pedersen, K.M., Vestergaard, H., et al. (1991) High incidence of multinodular toxic goitre in the elderly population in a low iodine area vs. high incidence of Graves' disease in the young in a high iodine area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine, 229, 415-420.
25. Belfiore, A., Sava, L., Runello, F., et al. (1983) Solitary autonomously functioning thyroid nodules and iodine deficiency. Journal of Clinical Endocrinology and Metabolism, 56, 283-287.
26. Hamburger, J.I., (1980) Evolution of toxicity in solitary non-toxic autonomously functioning thyroid nodules. Journal of Clinical Endocrinology and Metabolism, 50, 1089-1093.
27. Tamai, H., Kasagi, K., Takaichi, Y., et al. (1989) Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. Journal of Clinical Endocrinology and Metabolism, 69, 49-53.
28. Chung, H., Kim, W.B., Park, D.J., et al. (1999) Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies. Thyroid, 9, 393-399.